Trial Profile
A Phase 2 Study to Conduct Preliminary Evaluations of Safety, Pharmacodynamics and Efficacy by Intravenous Administration of MR11A8 in the Treatment of Patients with Moderate to Severe Acute Respiratory Distress Syndrome (MR11A8-1).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Adult respiratory distress syndrome
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Maruishi Pharmaceutical
- 10 Dec 2014 New trial record